Total Funding
78
1
Total FundingGrant raised
Growth Score 78 in past quarter
-10 pts
Heat Score 1 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4131211
Winston Pharmaceuticals is engaged in the development of pain management products.
David Starr: Vice President, CFOPast Role: Edlong Dairy Technologies, Chief Financial Officer- Joel E. Bernstein: Founder, CEO, Director
About the Company
Winston is a pharmaceutical company focused on developing pain management products for large pain-control markets, as well as on niche markets, where there are still significant needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston’s late-stage product candidates span a range of pain indications,
including episodic cluster headache, migraine and tension headache, osteo- and rheumatoid arthritis, neuropathic pain, cancer pain and pain associated with inflammatory bowel disease.
